Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023

Rhea-AI Summary

Twist Bioscience Corporation (NASDAQ: TWST) announced that Patrick Finn, Ph.D., will participate in the UBS MedTech, Tools and Genomics Summit 2023 panel on August 15. The panel will discuss Innovation Across Drug Discovery, Molecule Synthesis, & Precision Medicine. The event will be webcast live and available for replay on the company's investor relations website.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Patrick Finn, Ph.D., president and COO of Twist Bioscience, will participate in the Innovation Across Drug Discovery, Molecule Synthesis, & Precision Medicine panel at the UBS MedTech, Tools and Genomics Summit 2023 on Tuesday, August 15 at 2:00 p.m. Pacific Time.

The panel will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20230807075304/en/

For Twist Bioscience:

Angela Bitting

SVP, Corporate Affairs

925-202-6211

abitting@twistbioscience.com

Source: Twist Bioscience Corporation

FAQ

What is the company name or ticker symbol mentioned in the press release?

The company mentioned is Twist Bioscience Corporation (NASDAQ: TWST).

What event will Patrick Finn participate in?

Patrick Finn will participate in the UBS MedTech, Tools and Genomics Summit 2023 panel.

When will the panel take place?

The panel will take place on Tuesday, August 15 at 2:00 p.m. Pacific Time.

Where can the panel be accessed?

The panel can be accessed by visiting the 'Investor Calendar' page of the investor relations section of Twist Bioscience's website.

Will the presentation be available for replay?

Yes, a replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.